These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2181342)

  • 1. Kynurenine metabolites of tryptophan: implications for neurologic diseases.
    Freese A; Swartz KJ; During MJ; Martin JB
    Neurology; 1990 Apr; 40(4):691-5. PubMed ID: 2181342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan metabolites and brain disorders.
    Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
    Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenines in the mammalian brain: when physiology meets pathology.
    Schwarcz R; Bruno JP; Muchowski PJ; Wu HQ
    Nat Rev Neurosci; 2012 Jul; 13(7):465-77. PubMed ID: 22678511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics?
    Davis I; Liu A
    Expert Rev Neurother; 2015; 15(7):719-21. PubMed ID: 26004930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
    Shilov IuE; Bezrukov MV
    Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan metabolism in the central nervous system: medical implications.
    Ruddick JP; Evans AK; Nutt DJ; Lightman SL; Rook GA; Lowry CA
    Expert Rev Mol Med; 2006 Aug; 8(20):1-27. PubMed ID: 16942634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.
    Moroni F
    Eur J Pharmacol; 1999 Jun; 375(1-3):87-100. PubMed ID: 10443567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.
    Pocivavsek A; Schwarcz R; Erhardt S
    Pharmacol Rev; 2024 Oct; 76(6):978-1008. PubMed ID: 39304346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
    Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
    J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain.
    Kita T; Morrison PF; Heyes MP; Markey SP
    J Neurochem; 2002 Jul; 82(2):258-68. PubMed ID: 12124427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].
    Saito K
    Rinsho Byori; 1995 Sep; 43(9):891-901. PubMed ID: 7474452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids: Glutamatergic Transmission and Kynurenines.
    Colín-González AL; Aguilera G; Santamaría A
    Adv Neurobiol; 2016; 12():173-98. PubMed ID: 27651254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.
    Schwarcz R; Pellicciari R
    J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kynurenine and its metabolites in nervous system diseases].
    Vécsei L; Schwab F
    Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic Stroke and Kynurenines: Medicinal Chemistry Aspects.
    Hertelendy P; Toldi J; Fülöp F; Vécsei L
    Curr Med Chem; 2018; 25(42):5945-5957. PubMed ID: 29532751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An expanding range of targets for kynurenine metabolites of tryptophan.
    Stone TW; Stoy N; Darlington LG
    Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.